Nippon Shinyaku Co., Ltd. (OTCMKTS:NPNKF – Get Free Report) saw a large growth in short interest in the month of January. As of January 30th, there was short interest totaling 173,956 shares, a growth of 141.9% from the January 15th total of 71,910 shares. Based on an average daily trading volume, of 40 shares, the short-interest ratio is presently 4,348.9 days. Based on an average daily trading volume, of 40 shares, the short-interest ratio is presently 4,348.9 days.
Nippon Shinyaku Stock Performance
Nippon Shinyaku stock remained flat at $37.75 during midday trading on Friday. The business’s 50 day simple moving average is $37.37 and its 200-day simple moving average is $28.63. Nippon Shinyaku has a twelve month low of $21.00 and a twelve month high of $38.01.
Nippon Shinyaku Company Profile
Nippon Shinyaku Co, Ltd. operates as a research-driven pharmaceutical company headquartered in Kyoto, Japan. It specializes in the discovery, development, manufacture and marketing of therapeutic drugs across multiple therapeutic areas, including urology, hematology, oncology and internal medicine. The company’s business model integrates in-house research capabilities with strategic collaborations to bring novel small-molecule and biologic products to market.
Established in 1909 by entrepreneur Yorisuke Tsuji, Nippon Shinyaku has evolved from a domestic manufacturer into a global healthcare enterprise.
Further Reading
- Five stocks we like better than Nippon Shinyaku
- Your Bank Account Is No Longer Safe
- Nvidia CEO Issues Bold Tesla Call
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- New gold price target
Receive News & Ratings for Nippon Shinyaku Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nippon Shinyaku and related companies with MarketBeat.com's FREE daily email newsletter.
